Some people do experience ongoing digestive changes, such as slower gastric emptying or occasional constipation
Highlights The first incretin hormone, gastric inhibitory peptide, was identified in the early 1970s, followed by the discovery of glucagonlike peptide 1 (GLP-1) in the 1980s [1]
These medications are ideal for adults experiencing obesity or overweight, especially those with weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol
Contact your primary care provider or endocrinologist immediately if you experience persistent nausea or vomiting with semaglutide that prevents you from keeping food and medication downpoor absorption of levothyroxine could result
In recent years, GLP-1 medications like Ozempic and Wegovy have gained significant attention for their potential in managing obesity